Observational Study on Safety of Self-titration of Once Daily Levemir®
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The main objective of the study is to assess the safety of
self-titration in type 2 diabetic patients on antidiabetic tablets who are receiving insulin
for the first time. The study will also look at the blood glucose control, frequency of dose
adjustment, clinic visits, and time spent training patients to self-titrate.
The objective of diabetes management is to achieve blood glucose levels as close as possible
to normal in order to avoid late stage diabetic complications. Self-titration (where patients
adjust insulin dosage themselves) offers the potential for better blood glucose control than
titration only at clinic visits. In recent years treatment of type 2 diabetes in the United
Kingdom has moved from hospitals to GP surgeries or local clinics. Patients with type 2
diabetes, in general, have not been trained in self-titration to the same degree as patients
with type 1 diabetes. Less experience in self-titration could impact the level of blood
glucose control and outcome for these patients.
Data from this study will be pooled with data from NN304-3714 (NCT00825643) and will be
reported in the final study report for NN304-3714.